Asia-Pacific Alopecia Treatment Market to Grow Irrevocably over the Next 10 Years – KSU


Like all other verticals, the healthcare industry is poised to witness an amalgamation of collaborations and networks, as the culture of belonging and inclusion is the new DNA that is emerging. found there. In addition, remote working arrangements will be simplified with shared services, cloud technologies and AI in place. the Asia-Pacific Alopecia Treatment Market is intended to capture these events and provide insight into the same.

According to the latest market report released by Persistence Market Research, titled “Asia-Pacific Hair Loss Treatment Market: Industry Analysis and Forecast (2016-2024),” the Hair Loss Treatment market revenue alopecia in Asia-Pacific is expected to increase to a 6.6% CAGR during the forecast period 2016-2024.

In the report, the Asia-Pacific Alopecia Treatment market is analyzed on the basis of alopecia type, treatment type, and end-user. On the basis of alopecia type, the overall market has been segmented into alopecia areata, total alopecia, and universal alopecia. Topical medications (creams, oils, lotions, gels, shampoos, and mousse), oral medications, injectables (platelet rich plasma therapy, steroids, and injectable fillers), hair transplant services, and laser therapy. low level form the basis of the type of treatment.

Get started with a Sample of the Asia Pacific Alopecia Treatment Market Report!

Key players

  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Johnson & Johnson, Inc.
  • Reddy’s Laboratories Ltd.
  • Cipla Ltd.
  • Cellmid Ltd.
  • The Himalaya Drug Company
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Shiseido Co., Ltd.
  • Zhangguang 101 Science & Technology Co., Ltd

How about reinventing the methodical wheel in the Asia-Pacific alopecia treatment market? Go to the “Methodology” tab!

By end-user segment, the market has been segmented into hospitals, dermatology and trichology clinics, home care facilities, and cosmetic clinics. Across the market, oral solid dosage formulations are expected to gain increased acceptance due to the ease of consumption by patients in Asia Pacific. As a result, the oral drug segment is expected to experience an increase in the value of US $ 556.6 million in 2016 at US $ 1,005.1M by end of 2024.

The growing global demand for effective drugs for the treatment of hair loss, especially oral drugs, is the main driver of the market. Oral hair loss treatment drugs are growing in popularity because they help maintain patient safety with reduced number of drug doses but with increased drug effectiveness.

However, with changing lifestyles as well as increasing stress levels among the working class population, cosmeceutical drug makers focusing on expanding their line of hair treatment and hair treatment products. scalp, and the gaining momentum for the treatment of alopecia cytokine therapy are other factors which are expected to fuel the growth of the alopecia treatment market during the forecast period.

The expiration of patents for major blockbuster drugs, resulting in market exclusivity for some brands and various side effects associated with hair loss treatments, is expected to hamper the overall market growth. Some of the side effects such as allergies, depression and the risk of permanent sexual dysfunction. Other market deterrents include the limited effectiveness of hair loss treatment drugs and the lack of reimbursement for hair loss treatment services, such as laser treatments.

Keeping an eye on the major players in the Asia-Pacific alopecia treatment market? Go to “Buy Now” to decipher the competitive analysis in our Asia Pacific Alopecia Treatment Market Report!

On the basis of countries, the market has been divided into China, Japan, Australia and New Zealand, Malaysia, Singapore, India, Vietnam, Philippines and the rest of Asia-Pacific. Developed pharmaceutical markets such as China and Japan are expected to become the main supply markets.

This report assesses trends by type of alopecia, type of treatment, end user and country; to offer analytical information on the emerging potential demand for particular treatments for alopecia in specific regions. China is estimated to dominate the alopecia treatment market, accounting for maximum revenue share of the overall market by the end of 2016.

By the end of 2024, the Chinese and Japanese markets are expected to account for more than three-fifths of the Asia-Pacific alopecia treatment market revenue. In terms of market share by value, China is expected to maintain its dominant position, registering a CAGR of 7.1% during the forecast period.

About Us :-

Persistence Market Research is here to provide businesses with a one stop solution when it comes to improving customer experience. It is committed to collecting appropriate feedback after going through personalized customer interactions to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. The best possible returns are guaranteed there.

Contact us:

Persistence market research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
US Ph. – + 1-646-568-7751
USA-Canada Toll Free – + 1800-961-0353
Sales[email protected]
Website –

Source link

Leave A Reply

Your email address will not be published.